Intracerebellar administration of the chemokine Cxcl3 reduces the volume of medulloblastoma lesions at an advanced stage by promoting the migration and differentiation of preneoplastic precursor cells.

IF 5.8 2区 医学 Q1 CLINICAL NEUROLOGY
Brain Pathology Pub Date : 2024-06-30 DOI:10.1111/bpa.13283
Manuela Ceccarelli, Sabrina Rossi, Fabrizio Bonaventura, Roberto Massari, Annunziata D'Elia, Andrea Soluri, Laura Micheli, Giorgio D'Andrea, Barbara Mancini, Marcello Raspa, Ferdinando Scavizzi, Rita Alaggio, Francesca Del Bufalo, Evelina Miele, Andrea Carai, Angela Mastronuzzi, Felice Tirone
{"title":"Intracerebellar administration of the chemokine Cxcl3 reduces the volume of medulloblastoma lesions at an advanced stage by promoting the migration and differentiation of preneoplastic precursor cells.","authors":"Manuela Ceccarelli, Sabrina Rossi, Fabrizio Bonaventura, Roberto Massari, Annunziata D'Elia, Andrea Soluri, Laura Micheli, Giorgio D'Andrea, Barbara Mancini, Marcello Raspa, Ferdinando Scavizzi, Rita Alaggio, Francesca Del Bufalo, Evelina Miele, Andrea Carai, Angela Mastronuzzi, Felice Tirone","doi":"10.1111/bpa.13283","DOIUrl":null,"url":null,"abstract":"<p><p>The prognosis for many pediatric brain tumors, including cerebellar medulloblastoma (MB), remains dismal but there is promise in new therapies. We have previously generated a mouse model developing spontaneous MB at high frequency, Ptch1<sup>+/-</sup>/Tis21<sup>-/-</sup>. In this model, reproducing human tumorigenesis, we identified the decline of the Cxcl3 chemokine in cerebellar granule cell precursors (GCPs) as responsible for a migration defect, which causes GCPs to stay longer in the proliferative area rather than differentiate and migrate internally, making them targets of transforming insults. We demonstrated that 4-week Cxcl3 infusion in cerebella of 1-month-old mice, at the initial stage of MB formation, forces preneoplastic GCPs (pGCPs) to leave lesions and differentiate, with a complete suppression of MB development. In this study, we sought to verify the effect of 4-week Cxcl3 treatment in 3-month-old Ptch1<sup>+/-</sup>/Tis21<sup>-/-</sup> mice, when MB lesions are at an advanced, irreversible stage. We found that Cxcl3 treatment reduces tumor volumes by sevenfold and stimulates the migration and differentiation of pGCPs from the lesion to the internal cerebellar layers. We also tested whether the pro-migratory action of Cxcl3 favors metastases formation, by xenografting DAOY human MB cells in the cerebellum of immunosuppressed mice. We showed that DAOY cells express the Cxcl3 receptor, Cxcr2, and that Cxcl3 triggers their migration. However, Cxcl3 did not significantly affect the frequency of metastases or the growth of DAOY-generated MBs. Finally, we mapped the expression of the Cxcr2 receptor in human MBs, by evaluating a well-characterized series of 52 human MBs belonging to different MB molecular subgroups. We found that Cxcr2 was variably expressed in all MB subgroups, suggesting that Cxcl3 could be used for therapy of different MBs.</p>","PeriodicalId":9290,"journal":{"name":"Brain Pathology","volume":" ","pages":"e13283"},"PeriodicalIF":5.8000,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bpa.13283","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The prognosis for many pediatric brain tumors, including cerebellar medulloblastoma (MB), remains dismal but there is promise in new therapies. We have previously generated a mouse model developing spontaneous MB at high frequency, Ptch1+/-/Tis21-/-. In this model, reproducing human tumorigenesis, we identified the decline of the Cxcl3 chemokine in cerebellar granule cell precursors (GCPs) as responsible for a migration defect, which causes GCPs to stay longer in the proliferative area rather than differentiate and migrate internally, making them targets of transforming insults. We demonstrated that 4-week Cxcl3 infusion in cerebella of 1-month-old mice, at the initial stage of MB formation, forces preneoplastic GCPs (pGCPs) to leave lesions and differentiate, with a complete suppression of MB development. In this study, we sought to verify the effect of 4-week Cxcl3 treatment in 3-month-old Ptch1+/-/Tis21-/- mice, when MB lesions are at an advanced, irreversible stage. We found that Cxcl3 treatment reduces tumor volumes by sevenfold and stimulates the migration and differentiation of pGCPs from the lesion to the internal cerebellar layers. We also tested whether the pro-migratory action of Cxcl3 favors metastases formation, by xenografting DAOY human MB cells in the cerebellum of immunosuppressed mice. We showed that DAOY cells express the Cxcl3 receptor, Cxcr2, and that Cxcl3 triggers their migration. However, Cxcl3 did not significantly affect the frequency of metastases or the growth of DAOY-generated MBs. Finally, we mapped the expression of the Cxcr2 receptor in human MBs, by evaluating a well-characterized series of 52 human MBs belonging to different MB molecular subgroups. We found that Cxcr2 was variably expressed in all MB subgroups, suggesting that Cxcl3 could be used for therapy of different MBs.

Abstract Image

小脑内注射趋化因子Cxcl3可通过促进肿瘤前期前体细胞的迁移和分化,减少髓母细胞瘤晚期病变的体积。
包括小脑髓母细胞瘤(MB)在内的许多小儿脑肿瘤的预后仍然不容乐观,但新疗法大有可为。我们以前曾产生过一种高频率发生自发性小脑髓母细胞瘤的小鼠模型--Ptch1+/-/Tis21-/-。在这个重现人类肿瘤发生的模型中,我们发现小脑颗粒细胞前体(GCPs)中 Cxcl3 趋化因子的减少是导致迁移缺陷的原因,这导致 GCPs 在增殖区停留更长时间,而不是在内部分化和迁移,使它们成为转化性损伤的目标。我们证实,在 MB 形成的初期阶段,在 1 个月大的小鼠脑髓中注入 4 周的 Cxcl3 可迫使肿瘤前 GCP(pGCP)离开病灶并分化,从而完全抑制 MB 的发展。在本研究中,我们试图验证对 3 个月大的 Ptch1+/-/Tis21-/- 小鼠进行为期 4 周的 Cxcl3 治疗的效果,此时 MB 病变正处于不可逆的晚期阶段。我们发现,Cxcl3 治疗可使肿瘤体积缩小七倍,并刺激 pGCPs 从病灶向小脑内层迁移和分化。我们还通过在免疫抑制小鼠的小脑中异种移植 DAOY 人类 MB 细胞,检验了 Cxcl3 的促迁移作用是否有利于转移瘤的形成。我们发现,DAOY细胞表达Cxcl3受体Cxcr2,Cxcl3可诱导其迁移。然而,Cxcl3 并没有明显影响转移的频率或 DAOY 产生的 MB 的生长。最后,我们通过评估属于不同 MB 分子亚群的 52 例特征明确的人类 MB,绘制了 Cxcr2 受体在人类 MB 中的表达图。我们发现,Cxcr2 在所有 MB 亚群中都有不同程度的表达,这表明 Cxcl3 可用于治疗不同的 MB。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Brain Pathology
Brain Pathology 医学-病理学
CiteScore
13.20
自引率
3.10%
发文量
90
审稿时长
6-12 weeks
期刊介绍: Brain Pathology is the journal of choice for biomedical scientists investigating diseases of the nervous system. The official journal of the International Society of Neuropathology, Brain Pathology is a peer-reviewed quarterly publication that includes original research, review articles and symposia focuses on the pathogenesis of neurological disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信